Xenon Pharmaceuticals Inc. (XENE): Price and Financial Metrics
Xenon Pharmaceuticals Inc. (XENE)
Today's Latest Price: $13.38 USD
0.40 (-2.90%)
Updated May 27 4:00pm
Add XENE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
XENE Stock Summary
- Of note is the ratio of Xenon Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; just 10.87% of US stocks have a lower such ratio.
- With a price/sales ratio of 34.65, Xenon Pharmaceuticals Inc has a higher such ratio than 95.45% of stocks in our set.
- Revenue growth over the past 12 months for Xenon Pharmaceuticals Inc comes in at 297.34%, a number that bests 97.79% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Xenon Pharmaceuticals Inc are UMRX, LQDA, MCRB, KALV, and CLDX.
- XENE's SEC filings can be seen here. And to visit Xenon Pharmaceuticals Inc's official web site, go to www.xenon-pharma.com.
XENE Daily Price Range
XENE 52-Week Price Range
XENE Stock Price Chart More Charts
XENE Price/Volume Stats
| Current price | $13.38 | 52-week high | $18.45 |
| Prev. close | $13.78 | 52-week low | $7.00 |
| Day low | $12.50 | Volume | 149,200 |
| Day high | $13.86 | Avg. volume | 265,078 |
| 50-day MA | $12.37 | Dividend yield | N/A |
| 200-day MA | $11.90 | Market Cap | 467.95M |
Xenon Pharmaceuticals Inc. (XENE) Company Bio
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing differentiated therapeutics for orphan indications in Canada. The company was founded in 1996 and is based in Burnaby, Canada.
Loading social stream, please wait...